This document discusses endoscopic stent placement for malignant colonic obstruction. It outlines the indications, including palliation for surgically incurable colorectal cancer (CRC) and bridging to surgery to avoid emergent procedures. Contraindications include systemic toxicity, intra-abdominal abscess, coagulopathy, and distal rectal lesions. Self-expanding metal stents are commonly used and can be uncovered or covered. Complications of stent placement include perforation in 4% of cases, bleeding, abdominal pain, stent migration in 12% of cases, and stent occlusion. Failure of colonic decompression can also occur.
This document discusses endoscopic stent placement for malignant colonic obstruction. It outlines the indications, including palliation for surgically incurable colorectal cancer (CRC) and bridging to surgery to avoid emergent procedures. Contraindications include systemic toxicity, intra-abdominal abscess, coagulopathy, and distal rectal lesions. Self-expanding metal stents are commonly used and can be uncovered or covered. Complications of stent placement include perforation in 4% of cases, bleeding, abdominal pain, stent migration in 12% of cases, and stent occlusion. Failure of colonic decompression can also occur.
This document discusses endoscopic stent placement for malignant colonic obstruction. It outlines the indications, including palliation for surgically incurable colorectal cancer (CRC) and bridging to surgery to avoid emergent procedures. Contraindications include systemic toxicity, intra-abdominal abscess, coagulopathy, and distal rectal lesions. Self-expanding metal stents are commonly used and can be uncovered or covered. Complications of stent placement include perforation in 4% of cases, bleeding, abdominal pain, stent migration in 12% of cases, and stent occlusion. Failure of colonic decompression can also occur.
This document discusses endoscopic stent placement for malignant colonic obstruction. It outlines the indications, including palliation for surgically incurable colorectal cancer (CRC) and bridging to surgery to avoid emergent procedures. Contraindications include systemic toxicity, intra-abdominal abscess, coagulopathy, and distal rectal lesions. Self-expanding metal stents are commonly used and can be uncovered or covered. Complications of stent placement include perforation in 4% of cases, bleeding, abdominal pain, stent migration in 12% of cases, and stent occlusion. Failure of colonic decompression can also occur.
Indication for endoscopic stent placement - Palliation (surgically incurable CRC) - Bridge to surgery (avoid emergent two-step procedure + allow optimization of pt) - Mx for pts with extracolonic pelvic tumours (e.g. ovarian ca)
Contraindications - Systemic toxicity (à do emergency surgery) - Intra-abdominal abscess - Persistent coagulopathy - Distal rectal lesions (avoid due to tenesmus) Bevacizumab - High perforation rates - à Stent should be avoided in pts who are/will be receiving anti-angiogenic agents
Types of stents - Self-expanding metal stent (SEMS) o Uncovered (meshwork is bare wire) o Covered (meshwork covered à decrease tissue growth into the stent) § Mainly in malignant colo-vesical, colo-enteric, colo-vaginal fistulas § Less ingrowth, more migration Preprocedure - Bowel prep o Partial obstruction (distal) à cleansing water enemas o Partial obstruction (proximal) à oral bowel prep - Antibiotics (NOT needed for most, unless complete obstruction)
(Self-expanding metal stents, SEMS) – 25% cx rate -Respiratory compromise (respiratory depression, with hypoxia, hypercarbia) Sedation related -Cardiovascular instability -Vomiting & aspiration Procedure related - Perforation (4%) o Immediate or delayed o More in distal colon (sharp angulation & redundancy) o Cx: peritoneal seeding in CRC - Bleeding o Immediate § Tumour friability § Superficial tearing of stented tissue § Mucosal irritation o Delayed § Ulcerations / erosions - Abdominal pain o Transient (up to 5 days) à give analgesics Stent related - Stent migration (12%) o Stent too narrow/small/short o Colonic stricture is non obstructive o Tumour shrinks post chemo/RT - Stent occlusion o Tumour ingrowth through or overgrowth at either end of the stent o May require additional stent within the original stent - Recurrent obstruction (7%) - Failure of colonic decompression o Additional sites of intestinal obstruction (e.g. synchronous lesions) o Fecal impaction within a newly inserted stent o Incomplete stenting of the entire length o Early stent migration o Poor stent positioning o Incomplete stent expansion o Underlying motility disorder Assess o Retrograde contrast study (water soluble enema)